BlackRock’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Buy |
9,694,094
+145,261
| +2% | +$350K | ﹤0.01% | 2884 |
|
|
2025
Q1 | $21.1M | Sell |
9,548,833
-229,091
| -2% | -$506K | ﹤0.01% | 2868 |
|
|
2024
Q4 | $53.3M | Sell |
9,777,924
-698,159
| -7% | -$3.8M | ﹤0.01% | 2382 |
|
|
2024
Q3 | $87.1M | Buy |
10,476,083
+747,124
| +8% | +$6.21M | ﹤0.01% | 2142 |
|
|
2024
Q2 | $69.7M | Buy |
9,728,959
+3,314,335
| +52% | +$23.7M | ﹤0.01% | 2209 |
|
|
2024
Q1 | $55.6M | Sell |
6,414,624
-67,044
| -1% | -$581K | ﹤0.01% | 2342 |
|
|
2023
Q4 | $42.5M | Buy |
6,481,668
+554,360
| +9% | +$3.63M | ﹤0.01% | 2536 |
|
|
2023
Q3 | $59.3M | Buy |
5,927,308
+181,493
| +3% | +$1.81M | ﹤0.01% | 2277 |
|
|
2023
Q2 | $71.4M | Sell |
5,745,815
-154,100
| -3% | -$1.92M | ﹤0.01% | 2243 |
|
|
2023
Q1 | $82.7M | Buy |
5,899,915
+126,007
| +2% | +$1.77M | ﹤0.01% | 2111 |
|
|
2022
Q4 | $82.6M | Buy |
5,773,908
+78,397
| +1% | +$1.12M | ﹤0.01% | 2111 |
|
|
2022
Q3 | $145M | Sell |
5,695,511
-114,829
| -2% | -$2.93M | ﹤0.01% | 1699 |
|
|
2022
Q2 | $165M | Sell |
5,810,340
-171,554
| -3% | -$4.87M | 0.01% | 1654 |
|
|
2022
Q1 | $211M | Sell |
5,981,894
-71,153
| -1% | -$2.51M | 0.01% | 1627 |
|
|
2021
Q4 | $254M | Buy |
6,053,047
+1,420,288
| +31% | +$59.5M | 0.01% | 1561 |
|
|
2021
Q3 | $227M | Buy |
4,632,759
+700,552
| +18% | +$34.4M | 0.01% | 1611 |
|
|
2021
Q2 | $164M | Buy |
3,932,207
+708,029
| +22% | +$29.5M | ﹤0.01% | 1911 |
|
|
2021
Q1 | $115M | Buy |
3,224,178
+1,053,615
| +49% | +$37.6M | ﹤0.01% | 2097 |
|
|
2020
Q4 | $60.9M | Buy |
+2,170,563
| New | +$60.9M | ﹤0.01% | 2319 |
|